|
2003 Conference Publication Differences in lung function, growth parameters and frequency of hospital admissions between adolescents with cystic fibrosis-related diabetes and controlsMatson, A., McMahon, S., Bell, S. C., Batch, J. and Francis, P. (2003). Differences in lung function, growth parameters and frequency of hospital admissions between adolescents with cystic fibrosis-related diabetes and controls. 26th European CF Conference, Belfast, Ireland, 5–7 June 2003. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S1569-1993(03)00027-4 |
|
2003 Conference Publication Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosisO'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x |
|
2003 Conference Publication Vitamin A is associated with the inflammatory marker CRP in cystic fibrosisGreer, R., Buntain, H. M., Wainwright, C. E., Batch, J. A., Francis, P. W. and Bell, S. C. (2003). Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis. 26th Congress of the European Cystic Fibrosis Society, Belfast, Ireland, 5 Jun, 2003. Amsterdam: Elsevier BV. doi: 10.1016/j.jcf.2004.06.005 |
|
2003 Conference Publication Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosisO'Carroll, M. R., Coulter, C., Bell, S. C., Syrmis, M., Wainwright, C. E., Nissen, M. and Sloots, T. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. 26th European CF Conference, Belfast, Ireland, 5–7 June , 2003. Netherlands: Elsevier Science. doi: 10.1016/S1569-1993(03)00027-4 |
|
2002 Conference Publication A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF)Phillips, J., Bajramovic, J. and Bell, S. (2002). A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosisBowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, Queensland, 22-27 March, 2002. Carlton: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_1.x |
|
2002 Conference Publication Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999Cooper, P., McKay, K., Bobosevich, Z. and Bell, S. (2002). Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Cost of providing nutritional support for adult patients with cystif fibrosis (CF)McMillan, J., Matson, A., Matson, K. and Bell, S. (2002). Cost of providing nutritional support for adult patients with cystif fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Age appropriate pubertal development in cystic fibrosisBuntain, H., Greer, R. M., Schluter, P., Batch, J., Bell, S. C. and Wainwright, C. E. (2002). Age appropriate pubertal development in cystic fibrosis. The 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012 |
|
2002 Conference Publication Calcium homeostasis in patients with cystic fibrosisGreer, R., Buntain, H., Wainwright, C., Wong, J., Lewindon, P., Potter, J., Francis, P., O'Rourke, P., Munns, C., Batch, J. and Bell, S. (2002). Calcium homeostasis in patients with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x |
|
2002 Conference Publication Burkholderia cepacia (b.cepacia) complex: identification of genomovars in patients with cystic fibrosis (CF)Kidd, T., Coulter, C. and Bell, S. (2002). Burkholderia cepacia (b.cepacia) complex: identification of genomovars in patients with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Changes in nutritional parameters following lung transplantation for end stage cystic fibrosis (CF)Scott, A., Matson, A., Glanville, A., Morton, J. and Bell, S. (2002). Changes in nutritional parameters following lung transplantation for end stage cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosisBell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70010 |
|
2002 Conference Publication Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unitMatson, A., Walker, F., Matson, K. and Bell, S. C. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unit. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Antibiotic desensitisation in adults with cystic fibrosisBurrows, J., Toon, M. and Bell, S. C. (2002). Antibiotic desensitisation in adults with cystic fibrosis. SHPA State Conference 2002 - Reducing risk: the cornerstone of hospital pharmacy, Brisbane, 1-3 Nov. 2002. Brisbane: SHPA Qld. |
|
2002 Conference Publication Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axisGreer, R. M., Buntain, H., Wainwright, C. E., Potter, J. M., Munns, C., O'Rourke, P., Francis, P., Batch, J. and Bell, S. C. (2002). Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012 |
|
2002 Conference Publication Puberty and bone mineral accrual in cystic fibrosisBuntain, H. M., Greer, R. M., Batch, J., Wong, J., Lewindon, P., Schluter, P., Bell, S. C., Potter, J. and Wainwright, C. E. (2002). Puberty and bone mineral accrual in cystic fibrosis. TSANZ 2002 Annual Scientific Meeting. Respirology, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x |
|
2002 Conference Publication Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infectionGarske, L., Bunting, J., Franks, C., Masel, P. and Bell, S. (2002). Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia. |
|
2002 Conference Publication Prevalence of cystic fibrosis-related diabetes (CFRD), in an Australian adult cystic fibrosis (CF) unitMatson, A. G., Walker, F., Matson, K. M. and Bell, S. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD), in an Australian adult cystic fibrosis (CF) unit. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 Oct, 2002. New York: Wiley-Liss. |
|
2001 Conference Publication A prospective randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis (CF): Impact on clinical, laboratory and quality of life (QOL) outcomesSeeney, S. L., Bowler, S., Wolter, J.M., Bell, S.C., Masel, P.J. and McCormack, J. G. (2001). A prospective randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis (CF): Impact on clinical, laboratory and quality of life (QOL) outcomes. ASID Annual Scientific Meeting, Melbourne, Australia, 7-11 April, 2001. Carlton, Australia: Blackwell Science Asia. doi: 10.1046/j.1445-5994.2001.00318.x |
